Philips (NYSE:PHG) announced today that it received FDA 510(k) clearance for a number of remote imaging features.

The clearance paves the way for the launch of Medtronic’s Smart MDI system, which combines its InPen and Simplera continuous glucose monitor for people who take multiple daily insulin injections.